Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy
NCT ID: NCT04470102
Last Updated: 2020-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2020-03-12
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency.
NCT02054221
Mitral Valve in Hypertrophic Cardiomyopathy
NCT03877731
Surgical Treatment of Ischemic Mitral Regurgitation
NCT01368575
The Effectiveness of Surgical Treatment of Patients With Ischemic Cardiomyopathy
NCT04489355
Stress Echo for Ischemic Mitral Valve Surgery
NCT04023058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
isolated septal myectomy
Isolated extended septal myectomy
Septal myectomy
isolated extended septal myectomy
Septal myectomy+ "edge-to-edge"
advanced septal myectomy in combination with mitral valve repair using the edge-to-edge technique
mitral valve repair by edge-to-edge technique
transaortic access for mitral valve repair edge-to-edge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mitral valve repair by edge-to-edge technique
transaortic access for mitral valve repair edge-to-edge
Septal myectomy
isolated extended septal myectomy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indications for surgical treatment (septal myectomy) of hypertrophic cardiomyopathy
Exclusion Criteria
* Patient failure at any stage of the study
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meshalkin Research Institute of Pathology of Circulation
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander V. Bogachev-Prokophiev, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
E.Meshalkin National medical research center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
"E.Meshalkin National medical research center" of the Ministry of Health of the Russian Federation
Novosibirsk, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
188
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.